Immune responses in bladder cancer-role of immune cell populations, prognostic factors and therapeutic implications
M Joseph, D Enting - Frontiers in oncology, 2019 - frontiersin.org
Immunosurveillance, which describes the immunologically mediated elimination of
transformed cells, has been widely accepted in the context of bladder cancer for many …
transformed cells, has been widely accepted in the context of bladder cancer for many …
Checkpoint inhibition in bladder cancer: clinical expectations, current evidence, and proposal of future strategies based on a tumor-specific immunobiological …
M Mancini, M Righetto, E Noessner - Cancers, 2021 - mdpi.com
Simple Summary In contrast with other strategies, immunotherapy is a treatment aimed at
empowering the patient's immune system in order to increase immunity and the response …
empowering the patient's immune system in order to increase immunity and the response …
Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer
Long noncoding RNAs (lncRNAs) have been associated with cancer immunity regulation
and the tumor microenvironment (TME). However, functions of lncRNAs of tumor-infiltrating …
and the tumor microenvironment (TME). However, functions of lncRNAs of tumor-infiltrating …
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
C Martins-Lima, U Chianese, R Benedetti… - Frontiers in molecular …, 2023 - frontiersin.org
Bladder cancer (BlCa) is a highly immunogenic cancer. Bacillus Calmette-Guérin (BCG) is
the standard treatment for non-muscle invasive bladder cancer (NMIBC) patients and …
the standard treatment for non-muscle invasive bladder cancer (NMIBC) patients and …
[HTML][HTML] Exploring the Immunoresponse in Bladder Cancer Immunotherapy
I Ruiz-Lorente, L Gimeno, A López-Abad… - Cells, 2024 - mdpi.com
Bladder cancer (BC) represents a wide spectrum of diseases, ranging from recurrent non-
invasive tumors to advanced stages that require intensive treatments. BC accounts for an …
invasive tumors to advanced stages that require intensive treatments. BC accounts for an …
ZNF652‐Induced circRHOT1 Promotes SMAD5 Expression to Modulate Tumorigenic Properties and Nature Killer Cell‐Mediated Toxicity in Bladder Cancer via …
H Ke, J Zhang, F Wang, Y Xiong - Journal of Immunology …, 2021 - Wiley Online Library
Bladder cancer (BC) is the 9th most frequent diagnosed tumor and the 2nd most common
urology tumor worldwide. Despite the considerable advancement that BC treatment has …
urology tumor worldwide. Despite the considerable advancement that BC treatment has …
The neonatal Fc receptor in cancer FcRn in cancer
D Cadena Castaneda, G Brachet, C Goupille… - Cancer …, 2020 - Wiley Online Library
ABSTRACT Since the neonatal IgG Fc receptor (FcRn) was discovered, it was found to be
involved in immunoglobulin recycling and biodistribution, immune complexes routing …
involved in immunoglobulin recycling and biodistribution, immune complexes routing …
Immunotherapy for bladder cancer
AM Kamat, DL Lamm - Current urology reports, 2001 - Springer
The primary role of immunotherapy for bladder cancer is to treat superficial transitional cell
carcinomas (ie, carcinoma in situ, Ta, and T1). Immunotherapy in the form of bacille …
carcinomas (ie, carcinoma in situ, Ta, and T1). Immunotherapy in the form of bacille …
The use of natural killer cell activity and PPD test in the prediction of results in intravesical BCG treatment of patients with nonmuscle-invasive bladder cancer
G Yazici, E Gokmen, MG Kose, B Cetin… - … Urology and Nephrology, 2023 - Springer
Purpose To predict the efficacy of intravesical BCG therapy in patients with nonmuscle-
invasive bladder tumors (NIBC) by using components of the cellular immune response such …
invasive bladder tumors (NIBC) by using components of the cellular immune response such …
Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications
A Ariafar, E Kohansal, A Mousania… - Iranian Journal of …, 2024 - iji.sums.ac.ir
Background: Natural killer (NK) cells are crucial innate components in anti-tumor immunity.
However, the clinical impacts and their phenotypes in bladder cancer (BC) remain unclear …
However, the clinical impacts and their phenotypes in bladder cancer (BC) remain unclear …